Neurogene Inc
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurogene Inc and other ETFs, options, and stocks.About NGNE
Neurogene, Inc. is a clinical-stage biotechnology company, which engages in the development of product portfolio of genetic medicines for rare neurological diseases. The company was founded in May 2007 and is headquartered in New York, NY.
NGNE Key Statistics
Stock Snapshot
As of today, Neurogene Inc(NGNE) shares are valued at $30.90. The company's market cap stands at 497.29M, with a P/E ratio of -6.27.
As of 2026-06-30, Neurogene Inc(NGNE) stock has fluctuated between $28.12 and $32.96. The current price stands at $30.90, placing the stock +9.9% above today's low and -6.2% off the high.
The Neurogene Inc(NGNE)'s current trading volume is 162.06K, compared to an average daily volume of 251.53K.
During the past year, Neurogene Inc(NGNE) stock moved between $14.65 at its lowest and $37.27 at its peak.
During the past year, Neurogene Inc(NGNE) stock moved between $14.65 at its lowest and $37.27 at its peak.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.